Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | XDH | P47989 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245217 | 0.82 | GABRA1 (0.48) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL11033561 | 0.80 | GABRA1 (0.47) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL3045553 | 0.80 | GABRA1 (0.47) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL27592056 | 0.76 | GABRA1 (0.47) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL1420694 | 0.74 | GABRA1 (0.64) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL1744767 | 0.74 | GABRA1 (0.58) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL22493000 | 0.73 | GABRA1 (0.40) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL790696 | 0.73 | GABRA1 (0.41) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL15389161 | 0.72 | GABRA1 (0.47) | GABRA1GABRB2POLBXDHMEN1 | |
| SCHEMBL10981064 | 0.72 | GABRA1 (0.47) | GABRA1GABRB2POLBXDHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7179849-B2 | Antimicrobial compositions containing colloids of oligodynamic metals | C. R. BARD, INC. (US) | 2007-02-20 | — | — | US | claimed |
| EP-2948256-B1 | ANTISEPTIC APPLICATOR | CAREFUSION 2200 INC (US) | 2022-12-14 | — | — | EP | disclosed |
| EP-2173428-B1 | FOLEY CATHETER HAVING STERILE BARRIER | BARD INC C R (US) | 2018-10-10 | — | — | EP | disclosed |
| CN-103338732-B | Feminine care absorbent article for use in warm climates | 金伯利-克拉克环球有限公司 | 2016-08-10 | — | — | CN | disclosed |
| EP-2948256-A1 | ANTISEPTIC APPLICATOR | CareFusion 2200 Inc. (US) | 2015-12-02 | — | — | EP | disclosed |
| US-9119946-B2 | Antiseptic applicator | CAREFUSION 2200, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-9084838-B2 | Feminine care absorbent article for use in warm climates | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2015-07-21 | — | — | US | disclosed |
| WO-2014116482-A1 | ANTISEPTIC APPLICATOR | CAREFUSION 2200, INC. (US) | 2014-07-31 | — | — | WO | disclosed |
| US-20140205360-A1 | ANTISEPTIC APPLICATOR | CAREFUSION 2200, INC. (US) | 2014-07-24 | — | — | US | disclosed |
| CN-103338732-A | Feminine care absorbent article for use in warm climates | KIMBERLY CLARK CO | 2013-10-02 | — | — | CN | disclosed |
| US-20070048345-A1 | Antimicrobial composition | KIMBERLY-CLARK WORLDWIDE, INC. | 2007-03-01 | — | — | US | disclosed |
| US-7179849-B2 | Antimicrobial compositions containing colloids of oligodynamic metals | C. R. BARD, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| CN-1895672-A | Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use | LINXIANG BIOLOG TECHNOLOGY CO (CN) | 2007-01-17 | — | — | CN | disclosed |
| CN-1623394-A | Multielement syneryistic multifunction broad spectrum disinfectant and its application | HONG LIN (CN) | 2005-06-08 | — | — | CN | disclosed |
| US-20050042266-A1 | Cyanoacrylate compositions containing anti-microbial agent | CLOSURE MEDICAL CORPORATION (US) | 2005-02-24 | — | — | US | disclosed |
| EP-1508601-A1 | Cyanoacrylate compositions containing anti-microbial agent | Closure Medical Corporation (US) | 2005-02-23 | — | — | EP | disclosed |
| US-20040116551-A1 | Antimicrobial compositions containing colloids of oligodynamic metals | C.R. BARD, INC. | 2004-06-17 | — | — | US | disclosed |
| WO-2004017738-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING COLLOIDS OF OLIGODYNAMIC METALS | C.R. BARD, INC. (US) | 2004-03-04 | — | — | WO | disclosed |
| US-6503952-B2 | Mixture of chlorhexidine, quaternary ammonium salt and chlorinated phenol | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2003-01-07 | — | — | US | disclosed |
| US-20010016589-A1 | Mixture of chlorhexidine, quaternary ammonium salt and chlorinated phenol | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE | 2001-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070048345-A1 | Antimicrobial composition | MGAM, CUTA, CD68 | GABRA1 3280/4885GABRB2 3006/4885POLB 1632/4885 |
| US-20050042266-A1 | Cyanoacrylate compositions containing anti-microbial agent | CLSPN, PCNA, CDC73 | GABRA1 2131/4885GABRB2 2999/4885POLB 447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.